Denali Therapeutics Inc. (DNLI): 8-K filed Aug 6, 2026

Form type
8-K
Filing date
Aug 6, 2026
Accession number
0001714899-26-000096
Filer
Denali Therapeutics Inc. (CIK 1714899)